SilvaMarkovic-PleseMDMD PhD
Neurology • Philadelphia, PANeuroimmunology/Multiple Sclerosis
Professor of Neurology, Thomas Jefferson University, Philadelphia
Dr. Markovic-Plese is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
900 Walnut St
Philadelphia, PA 19107Phone+1 215-955-6871
Summary
- Dr. Silva Markovic-Plese is a neurologist in Thomas Jefferson University, Philadelphia. She received her medical degree from University of Zagreb Faculty of Medicine and has been in practice 30 years. She specializes in neuroimmunology/multiple sclerosis. She has more than 60 publications and over 500 citings.
Education & Training
Yale-New Haven Medical CenterResidency, Neurology, 1995 - 1998- Yale-New Haven Medical CenterInternship, Internal Medicine, 1994 - 1995
University of Zagreb Faculty of MedicineClass of 1988
Certifications & Licensure
PA State Medical License 2018 - 2024
NC State Medical License 2003 - 2018- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- EARLY IFNb-1a and Atorvastatin Combination Therapy of Isolated Clinical Syndrome Suggestive of Multiple Sclerosis Start of enrollment: 2004 Oct 01
- EARLY IFNB-1a and Simvastatin Combination Therapy in Clinically Isolated Syndrome Suggestive of Multiple Sclerosis Start of enrollment: 2004 Sep 01
- Characterization of Interferon Beta -1b-Induced Tolerizing Effect in Dendritic Cells Start of enrollment: 2007 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsTwenty Years of Subcutaneous Interferon-Beta-1a for Multiple Sclerosis: Contemporary Perspectives.Mark S Freedman, Patricia K Coyle, Kerstin Hellwig, Barry Singer, Daniel Wynn
Neurology and Therapy. 2024-04-01 - 1 citationsBlood-based targeted metabolipidomics reveals altered omega fatty acid-derived lipid mediators in relapsing-remitting multiple sclerosis patients.Insha Zahoor, Jeffrey Waters, Nasar Ata, Indrani Datta, Theresa L Pedersen
Biorxiv. 2024-01-06 - 26 citationsIL-11 induces NLRP3 inflammasome activation in monocytes and inflammatory cell migration to the central nervous system.Maryamsadat Seyedsadr, Yan Wang, Manal Elzoheiry, Sowmya Shree Gopal, Soohwa Jang
Proceedings of the National Academy of Sciences of the United States of America. 2023-06-27
Grant Support
- The Mechanisms Of Autoimmune Response Initiation In Multiple SclerosisNational Institute Of Neurological Disorders And Stroke2007
- The Mechanisms Of Autoimmune Response Initiation In MSNational Institute Of Neurological Disorders And Stroke2003–2006
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
